Therapeutic Group

Indication Dosage

Rivastigmine is a medication primarily prescribed to manage the symptoms of Alzheimer's disease and Parkinson's disease dementia. It is used to improve cognitive function, including memory, thinking, and reasoning abilities, in individuals experiencing these conditions. Rivastigmine works by increasing the levels of certain brain chemicals that are involved in memory and cognitive processes.

Mild To Moderate Dementia In Alzheimer's Disease: 

Oral: 

• Adult: Initially 1.5 Mg Twice Daily, Increased In Steps Of1.5 Mg Twice Daily, At Intervals Of At Least 2 Weeks According To Response And Tolerance; Usual Dose 3-6 Mg Twice Daily (max. Per Dose 6 Mg Twice Daily), If Treatment Interrupted For Several Days, Retitrate From 1.5mg Twice Daily 

By Transdermal Patches: 

• Adult: Apply 4.6 Mg/24 Hours Daily For At Least 4 Weeks, Increased If Tolerated To 9.5 Mg/24 Hours Daily For A Further 6 Months, Then Increased If Necessary To13.3 Mg/24 Hours Daily, Increase To 13.3 Mg/24 Hours Patch If Well Tolerated And Cognitive Deterioration Or Functional Decline Demonstrated; Use Caution In Patients With Body-weight Less Than 50 Kg, If Treatment Interrupted For More Than 3 Days, Retitrate From4.6 Mg/24 Hours Patch 

Mild To Moderate Dementia In Parkinson's Disease: 

• Adult: Initially 1.5 Mg Twice Daily, Increased In Steps Of1.5 Mg Twice Daily, Dose To Be Increased At Intervals Of At Least 2 Weeks According To Response And Tolerance; Usual Dose 3-6 Mg Twice Daily (max. Per Dose 6 Mg Twice Daily), If Treatment Interrupted For Several Days, Retitrate From 1.5mg Twice Daily.

Content

Pregnancy

Caution Advised

Stability

Contra Indications

Precautions

Lactation

Side Effects